WA
CVS icon

Wambolt & Associates’s CVS Health CVS Stock Holding History

Wambolt & Associates’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-6,673
Closed -$434K – 181
2020
Q2 		$434K Sell
6,673
-92
-1% -$5.79K 0.34% 112
2020
Q1 		$401K Sell
6,765
-635
-9% -$42.4K 0.41% 82
2019
Q4 		$550K Buy
7,400
+616
+9% +$43.3K 0.42% 76
2019
Q3 		$428K Buy
6,784
+55
+0.8% +$3.26K 0.35% 98
2019
Q2 		$367K Sell
6,729
-37
-0.5% -$1.99K 0.31% 114
2019
Q1 		$363K Buy
6,766
+264
+4% +$16.3K 0.33% 103
2018
Q4 		$426K Buy
+6,502
New +$485K 0.47% 67

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wambolt & Associates's CVS Position: Q3 2020 in Review

Wambolt & Associates sold out of CVS Health (CVS) in Q3 2020, closing a stake of 6,673 shares — an estimated $434K sold.

Wambolt & Associates first reported a position in CVS in Q4 2018 and held it in 7 quarters. The position peaked at $550K in Q4 2019. 1,815 funds tracked by Wall St. Rank hold CVS as of Q3 2020.

  • Wambolt & Associates reported no remaining CVS Health position as of Q3 2020 after selling out during the quarter.
  • Wambolt & Associates sold 6,673 CVS Health shares in Q3 2020, an estimated $434K.
  • Wambolt & Associates first reported a position in CVS Health in Q4 2018 and held it in 7 quarters.
  • Wambolt & Associates's CVS Health position peaked at $550K in Q4 2019.
  • 1,815 funds tracked by Wall St. Rank held CVS Health as of Q3 2020.

Based on Wambolt & Associates's 13F filing for Q3 2020, filed 4 Nov 2020.